Heavy losses for Ziopharm Oncology today as the stock fell by -€0.420 (-3.970%).
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Ziopharm Oncology.
As a result the target price of €4.00 shows a very positive potential of 60.000% compared to the current price of €2.50 for Ziopharm Oncology.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Ziopharm Oncology stock. Negative votes have not been in the majority for any criteria for this stock